Authors:
Vermeersch, P
Nong, Z
Stabile, E
Varenne, O
Gillijns, H
Pellens, M
Van Pelt, N
Hoylaerts, M
De Scheerder, I
Collen, D
Janssens, S
Citation: P. Vermeersch et al., L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism, ART THROM V, 21(10), 2001, pp. 1604-1609
Citation: J. Vermylen et al., Increased mortality with long-term platelet glycoprotein IIb/IIIa antagonists: An explanation?, CIRCULATION, 104(20), 2001, pp. E109-E109
Authors:
Jacquemin, M
Lavend'homme, R
Benhida, A
Vanzieleghem, B
d'Oiron, R
Lavergne, JM
Brackmann, HH
Schwaab, R
VandenDriessche, T
Chuah, MKL
Hoylaerts, M
Gilles, JGG
Peerlinck, K
Vermylen, J
Saint-Remy, JMR
Citation: M. Jacquemin et al., A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor, BLOOD, 96(3), 2000, pp. 958-965
Authors:
Gilles, JGG
Lavend'homme, R
Peerlinck, K
Jacquemin, MG
Hoylaerts, M
Jorieux, S
Mazurier, C
Vermylen, J
Saint-Remy, JMR
Citation: Jgg. Gilles et al., Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes, THROMB HAEM, 82(1), 1999, pp. 40-45